Please be aware that all information shared here at Canada Pharmacy has been medically reviewed and fact-checked for accuracy. These verifications are made by board-certified medical professionals who have the authority required to state that information related to medical conditions, symptoms, procedures and tests, and standard treatment protocols is valid and truthful. This is based on current guidelines and consensuses shared amongst medical professionals, and in representation of the latest research.
A generic drug is a copy of the brand-name drug with the same dosage, safety, strength, quality, consumption method, performance, and intended use. Before generics become available on the market, the generic company must prove it has the same active ingredients as the brand-name drug and works in the same way and in the same amount of time in the body.
The only differences between generics and their brand-name counterparts is that generics are less expensive and may look slightly different (eg. different shape or color), as trademarks laws prevent a generic from looking exactly like the brand-name drug.
Generics are less expensive because generic manufacturers don't have to invest large sums of money to develop a drug. When the brand-name patent expires, generic companies can manufacture a copy of the brand-name and sell it at a substantial discount.
Pomalyst (Pomalidomide) is a prescription drug used to treat multiple myeloma, a type of cancer that affects plasma cells in the bone marrow. It is typically prescribed to adults who have previously received at least two other therapies for multiple myeloma, including a proteasome inhibitor and lenalidomide. It is also used to treat AIDS-related Kaposi sarcoma (KS) in certain people. As an immunomodulatory drug, Pomalyst helps modify and regulate the immune system to fight against cancer cells.
For multiple myeloma treatment, the initial dose for adults is typically 4 milligrams (mg) taken orally once a day. This medication is usually taken on days 1 to 21 of a 28-day cycle, which is repeated every 28 days. Your doctor may adjust your dose as needed and tolerated, depending on your medical condition and response to treatment. It is crucial to always follow your doctor's instructions and never alter the dose without their guidance.
The active ingredient in Pomalyst is pomalidomide. In addition to the active ingredient, Pomalyst may contain several inactive ingredients that contribute to the formulation and stability of the medication. These may include mannitol, pregelatinized starch, and sodium stearyl fumarate.
Avoid using Pomalyst if you have a known history of hypersensitivity to Pomalidomide or any of the components. Pomalyst is also contraindicated in pregnancy due to its potential to cause severe birth defects or embryo-fetal death.
While Pomalyst can be effective, it may cause some side effects. The most common Pomalyst side effects may include fatigue, weakness, constipation, diarrhea, back pain, shortness of breath, and nausea. Serious side effects may include blood clots, heart attacks, stroke, and fetal birth defects. If you experience any side effects that persist or worsen, seek medical advice from a healthcare provider.